Navigation Links
Knome Announces KnomeDISCOVERY Research Awards Program
Date:4/28/2010

CAMBRIDGE, Mass., April 28 /PRNewswire/ -- Knome today announced the launch of its KnomeDISCOVERY Research Awards Program.  Given annually, the awards will fund innovative research projects that help reveal the genetic underpinnings of diseases and other important human traits. To inaugurate the program, Knome will award its exome sequencing and interpretation services to three winning research groups, each of which will study a pair of human exomes in order to answer a compelling biological question.  

Founded by Harvard geneticist George Church and led by internationally recognized scientists, clinicians, and bioinformaticians, Knome provides cutting-edge genome sequencing and interpretation services for biomedical researchers and families seeking to understand the causes of human disease.

"Genome sequence analysis is revolutionizing biomedical research.  My hope is that these awards will ignite researchers' imaginations," said George Church, Ph.D., Co-Founder & Chief Scientific Advisor of Knome. "Many experts in human disease stand to gain remarkable insights from exome sequencing, but could use guidance in interpreting the vast amount of data involved. Knome's sequence interpretation services can help such scientists play driving roles in the genomic revolution."

The company invites researchers to submit proposals before June 15, 2010; winners will be announced on July 30, 2010.  A panel of scientific advisors, led by George Church, will judge proposals on scientific merit, feasibility, and funding need.  Please see www.knome.com/awards for more information.

About Knome

Human genomics for disease investigation

Based in Cambridge, Mass., Knome is a leading human genomics company focused on providing secure, state-of-the-art sequencing and analysis solutions for biomedical researchers and motivated families that seek to understand the genetic underpinnings of disease. Led by internationally recognized geneticists, clinicians, and bioinformaticians, Knome is responsible for sequencing and interpreting more genomes than any other company in the world. Knome is a privately held company. For more information, please visit www.knome.com.


'/>"/>
SOURCE Knome
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Knome Featured in New PBS Series Faces of America with Henry Louis Gates, Jr.
2. Knome Launches First Platform-Agnostic Human Genome Sequencing and Analysis Service for Researchers
3. Scripps Announces Sale of United Medias Licensing Business for $175 Million
4. YM BioSciences announces controlled equity offering
5. MedQuist Announces Completion of Spheris Transaction
6. BIO-IT World Announces the Winners of its 2010 Best Practices Awards Program
7. Facet Solutions Announces 2 Year Data from US Pilot Study
8. Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer
9. Healthcare Data Solutions Announces Latest Database, PrescriberPRO@Home.
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
11. Gramene Announces Scholarships for Groups Underrepresented in Science to Learn How to Use Bioinformatics and Genomics Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
Breaking Biology Technology:
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
Breaking Biology News(10 mins):